R J Baldessarini, J F Lipinski. Show Affiliations »
Abstract
Mesh： See more » Antipsychotic Agents/adverse effectsAntipsychotic Agents/therapeutic useButyrophenones/adverse effectsButyrophenones/therapeutic useHumansLength of StayMental Disorders/drug therapyMental Disorders/therapyMovement Disorders/chemically inducedPhenothiazinesSulfides/adverse effectsSulfides/therapeutic useSyndromeTime FactorsTranquilizing Agents/adverse effectsTranquilizing Agents/therapeutic useXanthines/adverse effectsXanthines/therapeutic use
Substances： See more » Antipsychotic AgentsButyrophenonesPhenothiazinesSulfidesTranquilizing AgentsXanthines
Year: 1973 PMID： 4146359 DOI： 10.1056/NEJM197308232890812
Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245